| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nicotinic acid receptor activity | 3.53e-06 | 2 | 38 | 2 | GO:0070553 | |
| GeneOntologyMolecularFunction | protein sequestering activity | 3.65e-05 | 34 | 38 | 3 | GO:0140311 | |
| GeneOntologyMolecularFunction | molecular sequestering activity | 1.92e-04 | 59 | 38 | 3 | GO:0140313 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 7.95e-04 | 22 | 38 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 7.95e-04 | 22 | 38 | 2 | GO:0001614 | |
| GeneOntologyMolecularFunction | actinin binding | 3.03e-03 | 43 | 38 | 2 | GO:0042805 | |
| GeneOntologyBiologicalProcess | positive regulation of adiponectin secretion | 1.87e-05 | 4 | 37 | 2 | GO:0070165 | |
| GeneOntologyBiologicalProcess | adiponectin secretion | 8.71e-05 | 8 | 37 | 2 | GO:0070162 | |
| GeneOntologyBiologicalProcess | regulation of adiponectin secretion | 8.71e-05 | 8 | 37 | 2 | GO:0070163 | |
| Domain | HCAR2/3_rcpt | 3.82e-06 | 2 | 37 | 2 | IPR028017 | |
| Domain | EGF | 1.97e-03 | 126 | 37 | 3 | PF00008 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 28186140 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30154797 | ||
| Pubmed | The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. | 1.29e-06 | 2 | 40 | 2 | 24371223 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21774590 | ||
| Pubmed | The role of HCA2 (GPR109A) in regulating macrophage function. | 1.29e-06 | 2 | 40 | 2 | 23882124 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 36891315 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 36208084 | ||
| Pubmed | Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a. | 1.29e-06 | 2 | 40 | 2 | 38007572 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 26656756 | ||
| Pubmed | Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation. | 1.29e-06 | 2 | 40 | 2 | 37597514 | |
| Pubmed | The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism. | 1.29e-06 | 2 | 40 | 2 | 33924461 | |
| Pubmed | Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. | 1.29e-06 | 2 | 40 | 2 | 24691444 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 33977048 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 31347703 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 11745392 | ||
| Pubmed | Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis. | 1.29e-06 | 2 | 40 | 2 | 30659164 | |
| Pubmed | Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets. | 1.29e-06 | 2 | 40 | 2 | 25622782 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 33420329 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19223991 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12646212 | ||
| Pubmed | PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. | 1.29e-06 | 2 | 40 | 2 | 12563315 | |
| Pubmed | Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice. | 1.29e-06 | 2 | 40 | 2 | 23967184 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 26371038 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 34653248 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19136666 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 33488584 | ||
| Pubmed | Lactate-induced activation of HCA2 improves survival in mice with sepsis. | 1.29e-06 | 2 | 40 | 2 | 30951370 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 31858105 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30625381 | ||
| Pubmed | Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy. | 1.29e-06 | 2 | 40 | 2 | 32068460 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30657794 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30085883 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21655214 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 34092246 | ||
| Pubmed | (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. | 1.29e-06 | 2 | 40 | 2 | 15929991 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 36991440 | ||
| Pubmed | Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages. | 1.29e-06 | 2 | 40 | 2 | 25320346 | |
| Pubmed | Molecular identification of high and low affinity receptors for nicotinic acid. | 1.29e-06 | 2 | 40 | 2 | 12522134 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21441844 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30271409 | ||
| Pubmed | Niacin fine-tunes energy homeostasis through canonical GPR109A signaling. | 1.29e-06 | 2 | 40 | 2 | 30596513 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 35320002 | ||
| Pubmed | GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. | 1.29e-06 | 2 | 40 | 2 | 16322797 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 31914599 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 18983141 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 31366236 | ||
| Pubmed | Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes. | 1.29e-06 | 2 | 40 | 2 | 20655299 | |
| Pubmed | Evidence for constitutive dimerization of niacin receptor subtypes. | 1.29e-06 | 2 | 40 | 2 | 20380810 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 26116596 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 35649469 | ||
| Pubmed | GPR109A expressed on medullary thymic epithelial cells affects thymic Treg development. | 1.29e-06 | 2 | 40 | 2 | 37595951 | |
| Pubmed | The hypophagic response to heat stress is not mediated by GPR109A or peripheral β-OH butyrate. | 1.29e-06 | 2 | 40 | 2 | 26936786 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 34084164 | ||
| Pubmed | GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice. | 1.29e-06 | 2 | 40 | 2 | 35489706 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19561068 | ||
| Pubmed | Hyperhomocysteinemia is detrimental to pregnancy in mice and is associated with preterm birth. | 3.87e-06 | 3 | 40 | 2 | 23579073 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 37215085 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 20033346 | ||
| Pubmed | Niacin stimulates adiponectin secretion through the GPR109A receptor. | 3.87e-06 | 3 | 40 | 2 | 19141678 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 21454438 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 20664170 | ||
| Pubmed | Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. | 3.87e-06 | 3 | 40 | 2 | 24226773 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 34919284 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 23404113 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 27570060 | ||
| Pubmed | The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. | 3.87e-06 | 3 | 40 | 2 | 24845831 | |
| Pubmed | Oral Dimethyl Fumarate Targets HCA2-Expressing Skin Cells in the Imiquimod Mouse Model. | 3.87e-06 | 3 | 40 | 2 | 35189149 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 33597149 | ||
| Pubmed | Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. | 3.87e-06 | 3 | 40 | 2 | 17008386 | |
| Pubmed | Effects of high fat diet on GPR109A and GPR81 gene expression. | 3.87e-06 | 3 | 40 | 2 | 22842580 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 22914621 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 31710686 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 32093510 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 34852802 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 32358041 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 21317532 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 27332875 | ||
| Pubmed | Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation. | 7.73e-06 | 4 | 40 | 2 | 29514953 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 24412617 | ||
| Pubmed | The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. | 7.73e-06 | 4 | 40 | 2 | 25686106 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 38761195 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 25375133 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 19633298 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 25828455 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 22427566 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 19047060 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 35477756 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 19502010 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 29937375 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 32901017 | ||
| Pubmed | 2.98e-05 | 529 | 40 | 6 | 14621295 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 34626852 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 18429822 | ||
| Pubmed | Microbiota modulate sympathetic neurons via a gut-brain circuit. | 1.34e-04 | 15 | 40 | 2 | 32641826 | |
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 16177791 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 2.50e-04 | 1489 | 40 | 8 | 28611215 | |
| Pubmed | 4.56e-04 | 130 | 40 | 3 | 12421765 | ||
| Pubmed | 6.26e-04 | 32 | 40 | 2 | 31815296 | ||
| Pubmed | 6.26e-04 | 32 | 40 | 2 | 20301486 | ||
| Pubmed | 6.66e-04 | 33 | 40 | 2 | 24204828 | ||
| GeneFamily | Hydroxy-carboxylic acid receptors | 5.06e-06 | 3 | 24 | 2 | 200 | |
| Coexpression | GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN | 1.15e-05 | 200 | 39 | 5 | M6798 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-07 | 189 | 40 | 5 | 783c1db856f2defe6f3b8748dd0bc29a8102f6d1 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-07 | 189 | 40 | 5 | 88b72fafbe58463543e0818f27f3dd9e5b4d34d2 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.44e-07 | 190 | 40 | 5 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.44e-07 | 190 | 40 | 5 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 7.63e-07 | 191 | 40 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.12e-05 | 155 | 40 | 4 | 00eef9f93a753a1fe1ab5fd8dae026e7be556cde | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-05 | 171 | 40 | 4 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.98e-05 | 179 | 40 | 4 | d16dc58b5b22762a5a3c875563ced18022d08908 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.21e-05 | 184 | 40 | 4 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | 18-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 2.35e-05 | 187 | 40 | 4 | d1e301afcc39054ae1f867d80e564e30a137e3f8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 189 | 40 | 4 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 189 | 40 | 4 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 190 | 40 | 4 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 191 | 40 | 4 | 116fba9badea093e11f370996247cca0e4c02e8f | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.60e-05 | 192 | 40 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 192 | 40 | 4 | 12096302a3a4d26e21ca04357aa557143f482155 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 192 | 40 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-05 | 193 | 40 | 4 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.66e-05 | 193 | 40 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.71e-05 | 194 | 40 | 4 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.71e-05 | 194 | 40 | 4 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 2.77e-05 | 195 | 40 | 4 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-05 | 195 | 40 | 4 | ed052c6d3dc104b02e34b645abfdee477af050c6 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.77e-05 | 195 | 40 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 196 | 40 | 4 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.88e-05 | 197 | 40 | 4 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | proximal-Epithelial-Differentiating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.00e-05 | 199 | 40 | 4 | c607346f60e5997e757e5a31cab412ab3734377b | |
| ToppCell | proximal-3-Epithelial-Differentiating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.00e-05 | 199 | 40 | 4 | 12e07084fc2d5d4c418df564ccc0e132b056e549 | |
| ToppCell | proximal-Epithelial-Differentiating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.00e-05 | 199 | 40 | 4 | 96a89a2578fad9a99c52d2cf9e26e06516a96568 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 116 | 40 | 3 | df7609503782d8d7e4f31ed2a626916e5474d5bc | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.54e-04 | 116 | 40 | 3 | f32f7eddfe33adb3b5cf7c34667a481a305c5163 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 127 | 40 | 3 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | ASK452-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.25e-04 | 132 | 40 | 3 | 49ba24e24b3127b5257a88a0ee0246c9843c580a | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-04 | 133 | 40 | 3 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 2.46e-04 | 136 | 40 | 3 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | ASK454-Epithelial-Type_2|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.46e-04 | 136 | 40 | 3 | ff9a5e111993fdb3ac64c5ef269e3460ff994517 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-04 | 150 | 40 | 3 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-04 | 150 | 40 | 3 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.54e-04 | 154 | 40 | 3 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.61e-04 | 155 | 40 | 3 | 15bacd06cc2b02b13c85bb71c5b758e5ff613e80 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.03e-04 | 161 | 40 | 3 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.18e-04 | 163 | 40 | 3 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.18e-04 | 163 | 40 | 3 | f21951e63188eb0c04675a8f81a0da495c26c007 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.18e-04 | 163 | 40 | 3 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 4.18e-04 | 163 | 40 | 3 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | BAL-Severe-cDC_8|Severe / Compartment, Disease Groups and Clusters | 4.25e-04 | 164 | 40 | 3 | e8cbe7e01eca32886eb44e02d5333056b6bebc50 | |
| ToppCell | Club-club-16|World / Class top | 4.33e-04 | 165 | 40 | 3 | 684f3c4872bd630d3f744f15d57dccfd34e96160 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.49e-04 | 167 | 40 | 3 | d1a13d6ada572d8ddb2da95e6e122d2b705fad7f | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 4.49e-04 | 167 | 40 | 3 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.56e-04 | 168 | 40 | 3 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 4.64e-04 | 169 | 40 | 3 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 169 | 40 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-04 | 170 | 40 | 3 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 4.72e-04 | 170 | 40 | 3 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-04 | 170 | 40 | 3 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-04 | 170 | 40 | 3 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-04 | 170 | 40 | 3 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 4.81e-04 | 171 | 40 | 3 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 5.06e-04 | 174 | 40 | 3 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.06e-04 | 174 | 40 | 3 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.23e-04 | 176 | 40 | 3 | 8513c2a05a34453a16bbcf1c11cb34c580133e47 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 5.23e-04 | 176 | 40 | 3 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-04 | 178 | 40 | 3 | fb8f8d95f6b08378fb42c4076ee040276faa296f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-04 | 178 | 40 | 3 | a9ba4089413b1c55d667ce836b6972ca572ee2b8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-04 | 178 | 40 | 3 | 13dfd28a80889c2dacdc65b94a41bb9762dc409d | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-04 | 178 | 40 | 3 | b89c4d015b44bf538aa39969ef8778877c8023f1 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-04 | 179 | 40 | 3 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-04 | 179 | 40 | 3 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-04 | 179 | 40 | 3 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-04 | 179 | 40 | 3 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-04 | 179 | 40 | 3 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-04 | 179 | 40 | 3 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-04 | 180 | 40 | 3 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-04 | 180 | 40 | 3 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 5.58e-04 | 180 | 40 | 3 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-04 | 180 | 40 | 3 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-04 | 180 | 40 | 3 | 1c5515f29ead129bee3b4ca27799796956811a39 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-04 | 180 | 40 | 3 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.67e-04 | 181 | 40 | 3 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-04 | 181 | 40 | 3 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.67e-04 | 181 | 40 | 3 | faff2a34e391d053a17c926540e6cb46d94dd629 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.67e-04 | 181 | 40 | 3 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.67e-04 | 181 | 40 | 3 | 58651853f9c715075889856793df66ebe00c04f1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-04 | 181 | 40 | 3 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-04 | 181 | 40 | 3 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.67e-04 | 181 | 40 | 3 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.67e-04 | 181 | 40 | 3 | 5a9c332c0bf07cc20eaf8cf77b45e73668a6467d | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.67e-04 | 181 | 40 | 3 | 488a517f6e5543b648a2e72e0e04332fad776de6 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 5.76e-04 | 182 | 40 | 3 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 5.76e-04 | 182 | 40 | 3 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 183 | 40 | 3 | ecac1cfaff7553a60305b34d6cede6973ffb5430 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.85e-04 | 183 | 40 | 3 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.85e-04 | 183 | 40 | 3 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 183 | 40 | 3 | f6ebfd7f61e912f92bd07313cc213a171747ac03 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 5.95e-04 | 184 | 40 | 3 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.95e-04 | 184 | 40 | 3 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_progenitors|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.95e-04 | 184 | 40 | 3 | fcb5dd4fb3fa79f3b6029fad32a474cacde35a3b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-04 | 184 | 40 | 3 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.95e-04 | 184 | 40 | 3 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.95e-04 | 184 | 40 | 3 | 575de705053da8b289670b5c40c1627c0833b5ed | |
| Drug | histrionicotoxin | 7.00e-06 | 22 | 39 | 3 | CID005282247 | |
| Drug | Niacin | 1.71e-05 | 4 | 39 | 2 | DB00627 | |
| Disease | internal carotid intimal medial thickness | 1.70e-05 | 5 | 39 | 2 | EFO_0005053 | |
| Disease | Oral ulcer | 3.85e-04 | 107 | 39 | 3 | HP_0000155 | |
| Disease | Primary familial dilated cardiomyopathy | 7.23e-04 | 30 | 39 | 2 | cv:C0340427 | |
| Disease | Primary dilated cardiomyopathy | 9.30e-04 | 34 | 39 | 2 | cv:C0007193 | |
| Disease | triglyceride measurement, phospholipid measurement | 9.52e-04 | 146 | 39 | 3 | EFO_0004530, EFO_0004639 | |
| Disease | Paroxysmal atrial fibrillation | 1.15e-03 | 156 | 39 | 3 | C0235480 | |
| Disease | Persistent atrial fibrillation | 1.15e-03 | 156 | 39 | 3 | C2585653 | |
| Disease | familial atrial fibrillation | 1.15e-03 | 156 | 39 | 3 | C3468561 | |
| Disease | hepatocyte growth factor-like protein measurement | 1.16e-03 | 38 | 39 | 2 | EFO_0008154 | |
| Disease | Atrial Fibrillation | 1.24e-03 | 160 | 39 | 3 | C0004238 | |
| Disease | Secondary Biliary Cholangitis | 1.42e-03 | 42 | 39 | 2 | C0238065 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 1.42e-03 | 42 | 39 | 2 | C4551595 | |
| Disease | Biliary cirrhosis | 1.42e-03 | 42 | 39 | 2 | C0023892 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 1.49e-03 | 43 | 39 | 2 | DOID:12930 (is_implicated_in) | |
| Disease | Familial dilated cardiomyopathy | 1.55e-03 | 44 | 39 | 2 | C0340427 | |
| Disease | Primary biliary cirrhosis | 1.77e-03 | 47 | 39 | 2 | C0008312 | |
| Disease | Cardiomyopathy | 1.77e-03 | 47 | 39 | 2 | cv:C0878544 | |
| Disease | Metastatic melanoma | 2.33e-03 | 54 | 39 | 2 | C0278883 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.34e-03 | 200 | 39 | 3 | EFO_0004611, EFO_0020945 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.55e-03 | 206 | 39 | 3 | EFO_0004612, EFO_0020947 | |
| Disease | Skin Neoplasms | 2.78e-03 | 59 | 39 | 2 | C0037286 | |
| Disease | Malignant neoplasm of skin | 2.78e-03 | 59 | 39 | 2 | C0007114 | |
| Disease | HDL cholesterol change measurement, physical activity | 3.06e-03 | 62 | 39 | 2 | EFO_0003940, EFO_0007805 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAFSVPVRPFFSLGS | 446 | Q96KV6 | |
| SSAPSPYLRASFSSA | 391 | Q8N5Z0 | |
| FFASSRSTRPFSGFD | 111 | O75953 | |
| APTSACSPSFFDRFS | 1751 | Q6UB99 | |
| QSKFPIFRFPSSFSS | 396 | Q9H7T0 | |
| ASSSPEPSSITFFAF | 216 | Q8WTX7 | |
| SFFSSPSLANSIRSP | 166 | Q5TGY3 | |
| ARSFTQSSPTFPLAS | 491 | Q5T481 | |
| SLFSSSSQLFPPSRL | 681 | Q8TB72 | |
| PRGALDFASSFFSTP | 616 | Q9HCM3 | |
| TTAPFFSSSTLGSRP | 196 | P56975 | |
| TFSPAFSRPSAFSSL | 141 | O75112 | |
| TAFFSATADAASPFP | 1561 | Q8N201 | |
| SSPVFTSRSAAFSGR | 6 | P08729 | |
| FSSPSFPNFFSTLIN | 296 | Q8TDS4 | |
| PQSTSFFSPSFSLGL | 1806 | Q92817 | |
| PLSSPRFSGSAFSSV | 1321 | Q6ZNL6 | |
| GAPLLPFSSASFSSE | 816 | P23471 | |
| RLFTAPTFTGSFLSP | 541 | Q9NXE4 | |
| FASTSAPFTSLPFST | 396 | Q86XN7 | |
| APFTSLPFSTSSSAA | 401 | Q86XN7 | |
| TSSFDTVSSPRFPAN | 1626 | O60494 | |
| ALSNLPTFSSFSSDF | 3576 | Q9P2D7 | |
| FRKIRSSAPSSPSFS | 176 | Q5U4N7 | |
| SSSPLSSPRSPVFSF | 441 | Q8TDC3 | |
| SPRNFSPSASAHFSF | 261 | O15021 | |
| SFLPASFFSSSCLPV | 96 | Q6PEX3 | |
| FDSSAPFLASASTLF | 1396 | Q9NYQ7 | |
| SKFSDFPFPTRRASS | 246 | Q8N4H0 | |
| SPSSSSTSVGFFFRI | 141 | A6NKL6 | |
| FSSPSFPNFFSTLIN | 296 | P49019 | |
| SNRLADFSPTSPFST | 461 | Q5U5Q3 | |
| SSAAFSTRLAGPFPA | 296 | Q16512 | |
| SSFQGSPATPLSFLF | 16 | Q96M19 | |
| KPSSSDTFFRFSPSS | 786 | A0JNW5 | |
| FPTANSSFASPQFSP | 646 | Q92738 | |
| SSRPFRASSSTFFFQ | 521 | Q8IU68 | |
| TARAPYFSGSSTFSP | 511 | Q7Z4S6 | |
| RFESFSSPFSSQSAS | 236 | Q17R98 | |
| PFFSEDTFRQSPFTS | 761 | Q17R98 | |
| PFFPSFFLSLSLSPS | 81 | Q5T7P6 | |
| FATFSPSFPSLSAAN | 41 | O75954 | |
| FTAFLPDSTGSFTRR | 216 | P19838 |